Compare StocksABBV vs EW

AbbVie Inc. (ABBV) vs Edwards Lifesciences Corporation (EW)

ABBV
AbbVie Inc.
$206.23
VS
EW
Edwards Lifesciences Corporation
$82.46

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 71.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 83/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
EW
  • Edwards Lifesciences Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 78.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Edwards Lifesciences Corporation scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.0% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 87.0x is 39% above the historical average of 62.5x — the stock trades at a premium to its own history.
EW
  • FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 45.6x is 52% above the historical average of 30.1x — the stock trades at a premium to its own history.
  • 7 insider sales totaling $7.0M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
ABBV
EW
Valuation
$18.34B
Free Cash Flow
$1.17B
5.03%
FCF Yield
2.44%
87.02
Trailing P/E
45.56
12.80
Forward P/E
24.94
Quality & Moat
24.09%
ROIC
10.29%
N/A
ROE
10.38%
71.62%
Gross Margin
78.01%
N/A
PEG Ratio
N/A
Balance Sheet Safety
N/A
Debt / Equity
0.07
N/A
Interest Coverage
N/A
2.16
Net Debt / EBITDA
-1.96
3.36%
Dividend Yield
N/A
ABBV: 4Ties: 1EW: 3
ABBVEW

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

EW

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
EW
$0.62
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$6.65B
Δ Market Cap
+$4.12B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
694.9% Overvalued
Price is 694.9% above estimated fair value
Current Price: $206.23
Fair Value: $25.94
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
EW
46.3% Overvalued
Price is 46.3% above estimated fair value
Current Price: $82.46
Fair Value: $56.38
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $206?

+30.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +9.8%

The market implies +30.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +9.8%, reflecting heavy growth investment.

EW

What growth rate is the market pricing in at $82?

+17.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.4%

The market implies +17.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
83/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
EW
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
EW
-2.57
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.4%Retail & Other 23.5%
No. of Institutional Holders5,086
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
EW
Insiders 0.9%Institutions 91.5%Retail & Other 7.5%
No. of Institutional Holders1,884
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
EW
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
3
Sells (3M)
6
Sells (12M)
Total value (12M): $34.15M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
EW
7
Sells (3M)
29
Sells (12M)
Total value (12M): $16.22M
LIPPIS DANIEL J
Officer
$87,004
@ $85.38 · 2026-03-11
ULLEM SCOTT B
Chief Financial Officer
$1.10M
@ $84.92 · 2026-03-11
BOBO DONALD E JR
Officer
$974,430
@ $85.93 · 2026-03-02
BOBO DONALD E JR
Officer
$2.01M
@ $83.84 · 2026-02-25
ZOVIGHIAN BERNARD J
Chief Executive Officer
$1.72M
@ $76.67 · 2026-02-12
LIPPIS DANIEL J
Officer
$87,332
@ $85.70 · 2026-01-09
BOBO DONALD E JR
Officer
$971,429
@ $85.66 · 2026-01-06
BOBO DONALD E JR
Officer
$953,748
@ $83.76 · 2025-12-12
LIPPIS DANIEL J
Officer
$85,625
@ $84.03 · 2025-12-12
STONE HEISZ LESLIE
Director
$218,120
@ $83.41 · 2025-12-12
CHOPRA DAVEEN
Officer
$168,750
@ $84.38 · 2025-12-11
BOBO DONALD E JR
Officer
$950,581
@ $83.83 · 2025-12-10
ULLEM SCOTT B
Chief Financial Officer
$650,412
@ $84.47 · 2025-12-09
MARKOWITZ WAYNE
Officer
$50,144
@ $86.01 · 2025-12-08
ULLEM SCOTT B
Chief Financial Officer
$1.08M
@ $83.08 · 2025-11-10
LIPPIS DANIEL J
Officer
$84,196
@ $82.55 · 2025-11-10
CHOPRA DAVEEN
Officer
$204,865
@ $81.95 · 2025-08-25
WOOD LARRY L
Officer
$698,679
@ $78.06 · 2025-08-18
LIPPIS DANIEL J
Officer
$326,900
@ $79.46 · 2025-07-28
WOOD LARRY L
Officer
$673,268
@ $75.23 · 2025-06-16
BOBO DONALD E JR
Officer
$198,911
@ $77.40 · 2025-06-02
CHOPRA DAVEEN
Officer
$112,612
@ $75.07 · 2025-05-22
ULLEM SCOTT B
Chief Financial Officer
$837,035
@ $74.40 · 2025-05-09
LIPPIS DANIEL J
Officer
$24,560
@ $74.42 · 2025-05-09
MARKOWITZ WAYNE
Officer
$20,121
@ $75.08 · 2025-05-07
ZOVIGHIAN BERNARD J
Chief Executive Officer
$447,977
@ $74.91 · 2025-05-05
BOBO DONALD E JR
Officer
$663,196
@ $69.81 · 2025-04-14
LIPPIS DANIEL J
Officer
$21,183
@ $70.61 · 2025-04-08
ULLEM SCOTT B
Chief Financial Officer
$797,267
@ $70.87 · 2025-03-26
BOBO DONALD E JR
Officer
$645,624
@ $67.96 · 2025-03-13
LIPPIS DANIEL J
Officer
$27,792
@ $69.48 · 2025-03-10
ZOVIGHIAN BERNARD J
Chief Executive Officer
$428,448
@ $69.51 · 2025-03-10
ULLEM SCOTT B
Chief Financial Officer
$796,327
@ $70.78 · 2025-02-28
LORANGER STEVEN R
Director
$438,576
@ $76.42 · 2025-02-14
BOBO DONALD E JR
Officer
$492,363
@ $75.75 · 2025-02-13
ULLEM SCOTT B
Chief Financial Officer
$852,272
@ $75.76 · 2025-02-13
LIPPIS DANIEL J
Officer
$38,170
@ $76.34 · 2025-02-13
STONE HEISZ LESLIE
Director
$435,371
@ $75.86 · 2025-02-13
BOBO DONALD E JR
Officer
$343,736
@ $68.75 · 2025-01-16
LIPPIS DANIEL J
Officer
$34,382
@ $68.76 · 2025-01-16
LIPPIS DANIEL J
Officer
$185,196
@ $74.08 · 2024-12-16
BOBO DONALD E JR
Officer
$358,750
@ $71.75 · 2024-12-09
ULLEM SCOTT B
Chief Financial Officer
$806,406
@ $71.68 · 2024-12-09
CHOPRA DAVEEN
Officer
$128,223
@ $73.27 · 2024-12-06
MARKOWITZ WAYNE
Officer
$42,716
@ $73.27 · 2024-12-06
BOBO DONALD E JR
Officer
$327,843
@ $65.57 · 2024-11-13
WOOD LARRY L
Officer
$1.65M
@ $65.91 · 2024-11-05
BOBO DONALD E JR
Officer
$347,534
@ $69.51 · 2024-10-15
BOBO DONALD E JR
Officer
$333,826
@ $66.77 · 2024-09-11
CHOPRA DAVEEN
Officer
$87,438
@ $69.95 · 2024-08-20
BOBO DONALD E JR
Officer
$330,420
@ $66.08 · 2024-08-14
LIPPIS DANIEL J
Officer
$47,090
@ $94.18 · 2024-07-11
BOBO DONALD E JR
Officer
$466,474
@ $93.29 · 2024-07-10
LIPPIS DANIEL J
Officer
$48,150
@ $90.00 · 2024-06-20
ULLEM SCOTT B
Chief Financial Officer
$492,258
@ $87.51 · 2024-06-20
BOBO DONALD E JR
Officer
$437,696
@ $87.54 · 2024-06-12
ZOVIGHIAN BERNARD J
Chief Executive Officer
$755,539
@ $87.68 · 2024-05-30
ULLEM SCOTT B
Chief Financial Officer
$508,803
@ $90.45 · 2024-05-21
BOBO DONALD E JR
Officer
$439,038
@ $87.81 · 2024-05-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
EW
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
EW
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
View ABBV Full AnalysisView EW Full Analysis
AbbVie Inc. (ABBV) vs Edwards Lifesciences Corporation (EW) Stock Comparison | SafetyMargin.io